ANRS, Emerging Infectious Diseases clinical trials
Listed in the registry as: Government agency.
The registry lists 215 studies whose lead sponsor is ANRS, Emerging Infectious Diseases. 38 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 19, 2026.
Keep track of what changes. Save the ANRS, Emerging Infectious Diseases studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesStatus
Focus areas
Conditions ANRS, Emerging Infectious Diseases leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 215. Browse all 215 →
- OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy TrialRecruitingNCT05587894Phase 2
- Immunotherapy With Baricitinib and Sirolimus, Alone and in Combination, for the Control of HIV-1 Replication After Antiretroviral Treatment InterruptionNot yet recruitingNCT07081763Phase 2
- "HBV unIversal vs Point-Of-Care-based Antiviral treatMent to Prevent Mother-to-child Transmission"RecruitingNCT07054359Not applicable
- Frailty, Geriatric Syndromes and Care Pathways of Older Adults Living With HIV in West AfricaRecruitingNCT07355413
- Immunotherapy With Glatiramer Acetate in PLWHIV in Poor Immunological Responders on Antiretroviral TherapyNot yet recruitingNCT07851337Phase 2
- Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.RecruitingNCT05813964Phase 3
- Detection of Specific Metabolic Signatures by Nuclear Magnetic Resonance or Metabolomic NMR in Correlation With Markers of Inflammation or Immune Activation and the Risk of Developing Neurocognitive Disorders - Longitudinal Retrospective Study Nested in the ANRS12225 PEDIACAM III CohortNot yet recruitingNCT07770568
- DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 InfectionRecruitingNCT06203132Phase 3
- Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous MeningitisRecruitingNCT04145258Phase 3
- Intestinal Tissue-Resident Memory T Cells and HIV-1 Persistence During Antiretroviral TherapyNot yet recruitingNCT07656077Not applicable
- Prospective Cohort of People Starting Treatment for Tuberculosis Disease in France (FrenchTB)RecruitingNCT06893757
- An Experimental Medicine Multicenter Trial to Evaluate the Safety and Immunogenicity of Experimental Versus Authorized SARS-CoV-2 Vaccine Candidates as a Booster Dose in Healthy Participants Previously Vaccinated With Authorized mRNA SARS-CoV-2 Vaccines.RecruitingNCT07605520Early Phase 1
- Assessment of Immune Memory - Humoral and Cellular - in mPOX-infected Patients : an Ancillary Study of the ANRS0258s MOSAIC CohortNot yet recruitingNCT07592429Not applicable
- the ANRS CO21 " Extreme " Cohort (CODEX)RecruitingNCT01520844Not applicable
- "Pregnancy and Viral Infections: Impact on Pregnant Women and Their Children. French Prospective Cohort"Not yet recruitingNCT07412977
- Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy VolunteersNot yet recruitingNCT05202288Phase 2
- EBOla Post-Exposure ProphylaxisNot yet recruitingNCT06841614Phase 3
- Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy AdultsRecruitingNCT06821126Phase 1/2
- Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitisRecruitingNCT05590455Phase 2
- Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY TrialRecruitingNCT06522256Not applicable
- Diagnostics and Surveillance of Acute Meningo-encephalitis Among Children in Cambodia With a Focus on Japanese Encephalitis VirusNot yet recruitingNCT06674837
- Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 DiagnosisNot yet recruitingNCT07146529
- Access to Hepatitis C Treatment in Cameroon: Comparison of a Simplified Test and Treat Strategy to a Standard StrategyNot yet recruitingNCT07098481Phase 4
- Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a Booster in Volunteers.RecruitingNCT06255626Phase 1/2
- HIV-1 Non-group M in Cameroon : Study of Genotypic and Phylogenetic Diversity (OBSOCAM)Not yet recruitingNCT06913959
- Prevalence of Drug-resistant Hiv-1 Strains in Patients Experiencing Virologic Failure. (MULTIVIR2025)Not yet recruitingNCT06842706
- National Cohort of Patients Co-infected with Hepatitis B and Delta VirusesRecruitingNCT04166266
- Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected with the HIV-1 and HBV VirusesNot yet recruitingNCT06338826Phase 2
- A Study to Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Bictégravir, Emtricitabine and Ténofovir AlafénamideNot yet recruitingNCT05222945Not applicable
- DRug Use & Infections in ViEtnam: TuBerculosis ControlRecruitingNCT05655702Not applicable
- Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART ControlRecruitingNCT05300035Phase 2
- Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever VaccinationNot yet recruitingNCT05450770Not applicable
- Assisted Notification of Partners of Men Having Sex With Men Discovering Their SeropositivityNot yet recruitingNCT06419491Not applicable
- Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France.Not yet recruitingNCT06273943Phase 3
- Pilot Implementation of HIV Self-testing Delivery in Private Pharmacies Combined to a Respondent Driven Sampling Method to Improve HIV Testing for MSM and TGW in Phnom Penh - ANRS 0100sNot yet recruitingNCT05745168
- Assessment of HIV Remission Upon cART Interruption in Early Treated Individuals Carrying the MHC B35/53Bw4TTC2 GenotypeRecruitingNCT05482854Not applicable
- Seroprevalence of Monkeypox Infection Among People Living With HIV and PrEP UsersNot yet recruitingNCT05922735
- Primary Infection CohortRecruitingNCT03148964
- ANRS0268s POSTCOVIETCompletedNCT06022211
- Variants of SARS-CoV-2 Causing COVID-19 in AfricaCompletedNCT05311891
- ANRS 12372 MODERATO StudyCompletedNCT04022967Phase 3
- Evaluation of Measurement of Maternal Viral Load at Delivery to Optimise Post-natal Prophylaxis of HIV-exposed NewbornsCompletedNCT05017558
- Large Scale Transition to a Dolutegravir-based First-line ART in the South: Virological Response and Impact on HIV Drug Resistance in a Real Life Context (DoReaL Study)CompletedNCT05312918
- Covid-19 Vaccine Cohort in Specific PopulationsCompletedNCT04824651
- Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokombéré, Cameroon in Pregnant WomenActive, not recruitingNCT05403047Phase 4
- HPV Infection, Sexually Transmitted Infections and Anal Dysplasia in the Transgender PopulationCompletedNCT05981807
- Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) CoinfectionTerminatedNCT00158535Phase 2
- Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAARTCompletedNCT00196612Phase 3
- Antibody Responses to Pneumococcal Vaccines Among HIV-infected Adults.CompletedNCT00148824Phase 2
- Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-infected Patients in Virological Failure.CompletedNCT00196625Phase 2